The aquaglyceroporin AQP9 contributes to the sex-specific effects of in utero arsenic exposure on placental gene expression

Environmental Health: A Global Access Science Source

Volumn 16, Issue 1, 2017, Pages

  Winterbottom, Emily F ^a   Koestler, Devin C ^b   Fei, Dennis Liang ^a,c,d   Wika, Eric ^b   Capobianco, Anthony J ^a,e   Marsit, Carmen J ^f   Karagas, Margaret R ^c   Robbins, David J ^a,e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

AQP9; Arsenic; Fetal placenta; in utero

Indexed keywords

ARSENIC; AQP9 PROTEIN, HUMAN; AQUAPORIN; POLLUTANT;

ARSENIC; COHORT ANALYSIS; GENE EXPRESSION; NANOTECHNOLOGY; PHYSIOLOGICAL RESPONSE; PREGNANCY; PUBLIC HEALTH; SEX-RELATED DIFFERENCE; TOXICITY TEST;

AQP9 GENE; ARTICLE; COHORT ANALYSIS; FEMALE; FETUS; FETUS DEVELOPMENT; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; ADOLESCENT; ADULT; DRUG EFFECTS; GENETICS; MATERNAL EXPOSURE; METABOLISM; MIDDLE AGED; NEW HAMPSHIRE; PLACENTA; POLLUTANT; PREGNANCY; TOXICITY; YOUNG ADULT;

NEW HAMPSHIRE; UNITED STATES;

ADOLESCENT; ADULT; AQUAPORINS; ARSENIC; COHORT STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION; HUMANS; MALE; MATERNAL EXPOSURE; MIDDLE AGED; NEW HAMPSHIRE; PLACENTA; PREGNANCY; SEX FACTORS; YOUNG ADULT;

EID: 85020804579     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-017-0267-8     Document Type: Article

References (48)

1. Franconi F, Brunelleschi S, Steardo L, Cuomo V. Gender differences in drug responses. Pharmacol Res. 2007;55:81-95.
2. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol. 2009;76:215-28.
3. Aiken CE, Ozanne SE. Sex differences in developmental programming models. Reproduction. 2013;145:R1-13.
4. Gabory A, Roseboom TJ, Moore T, Moore LG, Junien C. Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ. 2013;4:5.
5. Clifton VL. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31(Suppl):S33-9.
6. Gluckman PD, Hanson MA, Beedle AS. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol. 2007;19:1-19.
7. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123:305-32.
8. Nordstrom DK. Public health. Worldwide occurrences of arsenic in ground water. Science. 2002;296:2143-5.
9. Bhattacharjee P, Chatterjee D, Singh KK, Giri AK. Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: an overview. Int J Hyg Environ Health. 2013;216:574-86.
10. Sohel N, Vahter M, Ali M, Rahman M, Rahman A, Streatfield PK, et al. Spatial patterns of fetal loss and infant death in an arsenic-affected area in Bangladesh. Int J Health Geogr. 2010;9:53.
11. Myers SL, Lobdell DT, Liu Z, Xia Y, Ren H, Li Y, et al. Maternal drinking water arsenic exposure and perinatal outcomes in inner Mongolia, China. J Epidemiol Community Health. 2010;64:325-9.
12. Llanos MN, Ronco AM. Fetal growth restriction is related to placental levels of cadmium, lead and arsenic but not with antioxidant activities. Reprod Toxicol. 2009;27:88-92.
13. Huyck KL, Kile ML, Mahiuddin G, Quamruzzaman Q, Rahman M, Breton CV, et al. Maternal arsenic exposure associated with low birth weight in Bangladesh. J Occup Environ Med. 2007;49:1097-104.
14. Xu L, Yokoyama K, Tian Y, Piao FY, Kitamura F, Kida H, et al. Decrease in birth weight and gestational age by arsenic among the newborn in Shanghai, China. Nihon Koshu Eisei Zasshi. 2011;58:89-95.
15. Rahman A, Vahter M, Ekstrom EC, Persson LA. Arsenic exposure in pregnancy increases the risk of lower respiratory tract infection and diarrhea during infancy in Bangladesh. Environ Health Perspect. 2011;119:719-24.
16. Farzan SF, Karagas MR, Chen Y. In utero and early life arsenic exposure in relation to long-term health and disease. Toxicol Appl Pharmacol. 2013;272:384-90.
17. Davis MA, Higgins J, Li Z, Gilbert-Diamond D, Baker ER, Das A, et al. Preliminary analysis of in utero low-level arsenic exposure and fetal growth using biometric measurements extracted from fetal ultrasound reports. Environ Health. 2015;14:12.
18. Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, et al. Karagas MR. Environ Health Perspect: Infant Infections and Respiratory Symptoms in Relation to Arsenic Exposure in a U.S. Cohort; 2015.
19. Gossai A, Lesseur C, Farzan S, Marsit C, Karagas MR, Gilbert-Diamond D. Association between maternal urinary arsenic species and infant cord blood leptin levels in a New Hampshire Pregnancy Cohort. Environ Res. 2015;136:180-6.
20. Green BB, Karagas MR, Punshon T, Jackson BP, Robbins DJ, Houseman EA, et al. Epigenome-Wide Assessment of DNA Methylation in the Placenta and Arsenic Exposure in the New Hampshire Birth Cohort Study (USA). Environ Health Perspect. 2016
21. Nadeau KC, Li Z, Farzan S, Koestler D, Robbins D, Fei DL, et al. In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort. Clin Immunol. 2014;155:188-97.
22. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M, El Arifeen S, et al. Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol. 2009;169:304-12.
23. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, Gibb H, et al. Arsenic exposure from drinking water and birth weight. Epidemiology. 2003;14:593-602.
24. Hamadani JD, Tofail F, Nermell B, Gardner R, Shiraji S, Bottai M, et al. Critical windows of exposure for arsenic-associated impairment of cognitive function in pre-school girls and boys: a population-based cohort study. Int J Epidemiol. 2011;40:1593-604.
25. Winterbottom EF, Fei DL, Koestler DC, Giambelli C, Wika E, Capobianco AJ, et al. GLI3 links environmental arsenic exposure and human fetal growth. EBioMedicine. 2015;2:536-43.
26. Fei DL, Koestler DC, Li Z, Giambelli C, Sanchez-Mejias A, Gosse JA, et al. Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study. Environ Health. 2013;12:58.
27. Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, et al. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci U S A. 2011;108:20656-60.
28. Koestler DC, Avissar-Whiting M, Houseman EA, Karagas MR, Marsit CJ. Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero. Environ Health Perspect. 2013;121:971-7.
29. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118-27.
30. Liu Z, Styblo M, Rosen BP. Methylarsonous acid transport by aquaglyceroporins. Environ Health Perspect. 2006;114:527-31.
31. Mukhopadhyay R, Bhattacharjee H, Rosen BP. Aquaglyceroporins: generalized metalloid channels. Biochim Biophys Acta. 1840;2014:1583-91.
32. Damiano AE. Review: Water channel proteins in the human placenta and fetal membranes. Placenta. 2011;32(Suppl 2):S207-11.
33. Khairul I, Wang QQ, Jiang YH, Wang C, Naranmandura H. Metabolism, toxicity and anticancer activities of arsenic compounds. Oncotarget. 2017;8:23905-26.
34. Torres-Avila M, Leal-Galicia P, Sanchez-Pena LC, Del Razo LM, Gonsebatt ME. Arsenite induces aquaglyceroporin 9 expression in murine livers. Environ Res. 2010;110:443-7.
35. Lebeck J, Gena P, O'Neill H, Skowronski MT, Lund S, Calamita G, et al. Estrogen prevents increased hepatic aquaporin-9 expression and glycerol uptake during starvation. Am J Physiol Gastrointest Liver Physiol. 2012;302:G365-74.
36. Lebeck J. Metabolic impact of the glycerol channels AQP7 and AQP9 in adipose tissue and liver. J Mol Endocrinol. 2014;52:R165-78.
37. Druwe IL, Vaillancourt RR. Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol. 2010;84:585-96.
38. Maciaszczyk-Dziubinska E, Wawrzycka D, Wysocki R. Arsenic and antimony transporters in eukaryotes. Int J Mol Sci. 2012;13:3527-48.
39. Hall M, Gamble M, Slavkovich V, Liu X, Levy D, Cheng Z, et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect. 2007;115:1503-9.
40. Punshon T, Davis MA, Marsit CJ, Theiler SK, Baker ER, Jackson BP, et al. Placental arsenic concentrations in relation to both maternal and infant biomarkers of exposure in a US cohort. J Expo Sci Environ Epidemiol. 2015;25:599-603.
41. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol. 2009;19:59-68.
42. Damiano AE, Zotta E, Ibarra C. Functional and molecular expression of AQP9 channel and UT-A transporter in normal and preeclamptic human placentas. Placenta. 2006;27:1073-81.
43. Zhang HJ, Siu MK, Wong ES, Wong KY, Li AS, Chan KY, et al. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. Placenta. 2008;29:549-54.
44. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998;44:185-90.
45. Al-Qattan MM, Shamseldin HE, Salih MA, Alkuraya FS. GLI3-related polydactyly: a review. Clin Genet. 2017; doi: 10.1111/cge.12952.
46. Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen BM, Enders H, et al. Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet. 2007;39:833-5.
47. Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, Kou YC, et al. Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet. 2007;39:836-8.
48. Rosenfeld CS. Sex-Specific Placental Responses in Fetal Development. Endocrinology. 2015;156:3422-34.